97 related articles for article (PubMed ID: 14534682)
1. The usefulness of 99mTc-tetrofosmin SPECT in monitoring the response to chemotherapy in lung cancer patients.
Spanu A; Ginesu F; Pirina P; Schillaci O; Farris A; Chessa F; Madeddu G; Falchi A; Madeddu G
Oncol Rep; 2003; 10(6):1701-7. PubMed ID: 14534682
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions.
Spanu A; Ginesu F; Pirina P; Solinas ME; Schillaci O; Farris A; Chessa F; Madeddu G; Marongiu P; Falchi A; Nuvoli S; Madeddu G
Int J Oncol; 2003 Mar; 22(3):639-49. PubMed ID: 12579319
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
4. (99m)Tc-3PRGD 2 SPECT/CT predicts the outcome of advanced nonsquamous non-small cell lung cancer receiving chemoradiotherapy plus bevacizumab.
Ma Q; Min K; Wang T; Chen B; Wen Q; Wang F; Ji T; Gao S
Ann Nucl Med; 2015 Jul; 29(6):519-27. PubMed ID: 25911312
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m tetrofosmin SPECT predicts chemotherapy response in small cell lung cancer.
Yeh JJ; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
Tumour Biol; 2003; 24(3):151-5. PubMed ID: 14610319
[TBL] [Abstract][Full Text] [Related]
6. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT.
Schillaci O; Spanu A; Scopinaro F; Monteleone F; Solinas ME; Volpino P; Pirina P; Marongiu P; Cangemi V; Madeddu G
J Nucl Med; 2003 Aug; 44(8):1219-24. PubMed ID: 12902410
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation.
Spanu A; Schillaci O; Pirina P; Arru A; Madeddu G; Chessa F; Marongiu P; Solinas ME; Madeddu G
Oncol Rep; 2006 Oct; 16(4):763-9. PubMed ID: 16969491
[TBL] [Abstract][Full Text] [Related]
8. Scintigraphic prediction of response to chemotherapy in patients with breast cancer: Technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography.
Takeuchi N; Fukumoto M; Nishioka A; Akagi N; Murata Y; Takeuchi S; Ogawa Y; Yoshida S
Int J Oncol; 2002 Jan; 20(1):53-8. PubMed ID: 11743642
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of 99mTc-tetrofosmin SPECT scintimammography in the detection of small size primary breast carcinomas.
Spanu A; Schillaci O; Meloni GB; Porcu A; Cottu P; Nuvoli S; Falchi A; Chessa F; Solinas ME; Madeddu G
Int J Oncol; 2002 Oct; 21(4):831-40. PubMed ID: 12239623
[TBL] [Abstract][Full Text] [Related]
10. (99m)Tc-3P-RGD2 SPECT to monitor early response to bevacizumab therapy in patients with advanced non-small cell lung cancer.
Chen B; Zhao G; Ma Q; Ji B; Ji T; Xin H; Gao S
Int J Clin Exp Pathol; 2015; 8(12):16064-72. PubMed ID: 26884883
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of chemotherapy response in patients with small cell lung cancer using Technetium-99m-tetrofosmin.
Kao CH; Ho YJ; Shen YY; Lee JK
Anticancer Res; 1999; 19(3B):2311-5. PubMed ID: 10472350
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of 9mTc-HL91 SPECT hypoxia imaging in patients with advanced NSCLC].
Li L; Yu JM; Sun XD; Zhu H; Yue JB; Sun CJ; Yang GR
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):127-30. PubMed ID: 17645850
[TBL] [Abstract][Full Text] [Related]
13. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
[TBL] [Abstract][Full Text] [Related]
14. To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression.
Kuo TH; Liu FY; Chuang CY; Wu HS; Wang JJ; Kao A
Nucl Med Biol; 2003 Aug; 30(6):627-32. PubMed ID: 12900288
[TBL] [Abstract][Full Text] [Related]
15. To predict chemotherapy response using technetium-99m tetrofosmin and compare with p-glycoprotein and multidrug resistance related protein-1 expression in patients with untreated small cell lung cancer.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Cancer Lett; 2001 Aug; 169(2):181-8. PubMed ID: 11431107
[TBL] [Abstract][Full Text] [Related]
16. Intracranial tumors after radiation therapy: role of 99mTc-tetrofosmin SPECT/CT with a hybrid camera.
Filippi L; Santoni R; Nicolì P; Danieli R; Schillaci O
Cancer Biother Radiopharm; 2009 Apr; 24(2):229-35. PubMed ID: 19409045
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m tetrofosmin single photon emission computed tomography in the evaluation of suspected lung cancer.
Schillaci O; Monteleone F; D'Andrea N; Picardi V; Cangemi R; Cangemi V; Scopinaro F
Cancer Biother Radiopharm; 1999 Apr; 14(2):129-34. PubMed ID: 10850296
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m tetrofosmin chest imaging related to p-glycoprotein expression for predicting the response with paclitaxel-based chemotherapy for non-small cell lung cancer.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Lung; 2001; 179(4):197-207. PubMed ID: 11891611
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging.
Soricelli A; Cuocolo A; Varrone A; Discepolo A; Tedeschi E; Mainenti PP; Grivet-Fojaja MR; Covelli EM; Postiglione A; Salvatore M
J Nucl Med; 1998 May; 39(5):802-6. PubMed ID: 9591579
[TBL] [Abstract][Full Text] [Related]
20. Scintigraphic prediction of resistance to radiation and chemotherapy in patients with lung carcinoma: technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography study.
Fukumoto M; Yoshida D; Hayase N; Kurohara A; Akagi N; Yoshida S
Cancer; 1999 Oct; 86(8):1470-9. PubMed ID: 10526275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
